Geoffrey O'Neill
Corporate Officer/Principal at The Trustees of Columbia University in The City of New York
Geoffrey O'Neill active positions
| Companies | Position | Start | End |
|---|---|---|---|
| The Trustees of Columbia University in The City of New York | Corporate Officer/Principal | - | - |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | Corporate Officer/Principal | - | - |
Career history of Geoffrey O'Neill
Former positions of Geoffrey O'Neill
| Companies | Position | Start | End |
|---|---|---|---|
| BMXP Holdings, Inc. | President | - | 2008-06-10 |
Frezer, Inc.
 Frezer, Inc. Medical SpecialtiesHealth Technology The Company's principal activity is to develop medical devices. The Company develops Cryogenic Stem Cell Banks. Stem cell banking provides the patient the necessary building blocks for future regenerative medical treatments. Regenerative Medicine helps in finding treatments for diabetes, Parkinson's disease and other degenerative diseases. The Company is in development stage. | President | 2005-05-01 | 2007-02-21 |
| Bio-Matrix Scientific Group, Inc. /Old/ | President | - | 2006-08-27 |
Statistics
International
| United States | 6 |
Operational
| President | 3 |
| Corporate Officer/Principal | 2 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 3 |
|---|---|
| Bio-Matrix Scientific Group, Inc. /Old/ | Health Technology |
| BMXP Holdings, Inc. | Health Technology |
Frezer, Inc.
Frezer, Inc. Medical SpecialtiesHealth Technology The Company's principal activity is to develop medical devices. The Company develops Cryogenic Stem Cell Banks. Stem cell banking provides the patient the necessary building blocks for future regenerative medical treatments. Regenerative Medicine helps in finding treatments for diabetes, Parkinson's disease and other degenerative diseases. The Company is in development stage. | Health Technology |
- Stock Market
- Insiders
- Geoffrey O'Neill
- Experience
